Geode Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Sell |
553,602
-597,420
| -52% | -$433K | ﹤0.01% | 3625 |
|
|
2025
Q1 | $991K | Buy |
1,151,022
+8,480
| +0.7% | +$7.3K | ﹤0.01% | 3307 |
|
|
2024
Q4 | $1.92M | Buy |
1,142,542
+7,000
| +0.6% | +$11.8K | ﹤0.01% | 3142 |
|
|
2024
Q3 | $3.24M | Buy |
1,135,542
+811
| +0.1% | +$2.31K | ﹤0.01% | 2958 |
|
|
2024
Q2 | $2.66M | Buy |
1,134,731
+27,780
| +3% | +$65K | ﹤0.01% | 3036 |
|
|
2024
Q1 | $3.25M | Buy |
1,106,951
+41,697
| +4% | +$123K | ﹤0.01% | 2913 |
|
|
2023
Q4 | $3.19M | Buy |
1,065,254
+50,687
| +5% | +$152K | ﹤0.01% | 2919 |
|
|
2023
Q3 | $3.21M | Buy |
1,014,567
+8,101
| +0.8% | +$25.6K | ﹤0.01% | 2868 |
|
|
2023
Q2 | $3.9M | Buy |
1,006,466
+12,780
| +1% | +$49.5K | ﹤0.01% | 2826 |
|
|
2023
Q1 | $2.75M | Buy |
993,686
+32,818
| +3% | +$90.9K | ﹤0.01% | 2902 |
|
|
2022
Q4 | $1.73M | Buy |
960,868
+5,799
| +0.6% | +$10.4K | ﹤0.01% | 3109 |
|
|
2022
Q3 | $2.02M | Buy |
955,069
+4,290
| +0.5% | +$9.09K | ﹤0.01% | 3078 |
|
|
2022
Q2 | $2.56M | Buy |
950,779
+424,473
| +81% | +$1.14M | ﹤0.01% | 3027 |
|
|
2022
Q1 | $2.28M | Buy |
526,306
+31,108
| +6% | +$135K | ﹤0.01% | 3196 |
|
|
2021
Q4 | $2.57M | Buy |
495,198
+109,327
| +28% | +$566K | ﹤0.01% | 3256 |
|
|
2021
Q3 | $2.37M | Buy |
385,871
+320,474
| +490% | +$1.97M | ﹤0.01% | 3274 |
|
|
2021
Q2 | $660K | Buy |
+65,397
| New | +$660K | ﹤0.01% | 3808 |
|